RAP1 anticorps (C-Term) (FITC)
-
- Antigène Voir toutes RAP1 (TERF2IP) Anticorps
- RAP1 (TERF2IP) (Telomeric Repeat Binding Factor 2, Interacting Protein (TERF2IP))
-
Épitope
- AA 348-378, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp RAP1 est conjugé à/à la FITC
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- TERF2IP, CT (TERF2IP, DRIP5, RAP1, Telomeric repeat-binding factor 2-interacting protein 1, Dopamine receptor-interacting protein 5, Repressor/activator protein 1 homolog) (FITC)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- TERF2IP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 348-378 amino acids from the C-terminal region of human TERF2IP.
- Isotype
- IgG
- Top Product
- Discover our top product TERF2IP Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- RAP1 (TERF2IP) (Telomeric Repeat Binding Factor 2, Interacting Protein (TERF2IP))
- Autre désignation
- TERF2IP (TERF2IP Produits)
- Synonymes
- anticorps DRIP5, anticorps RAP1, anticorps Rap1, anticorps cRAP1, anticorps TERF2 interacting protein, anticorps telomeric repeat binding factor 2, interacting protein, anticorps TERF2IP, anticorps Terf2ip
- NCBI Accession
- NP_061848
- UniProt
- Q9NYB0
- Pathways
- Cycle Cellulaire, Telomere Maintenance
-